Atlas Trials

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Clinical trial NCT07079150 · RECRUITING

Trial details

NCT number
NCT07079150
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
RECRUITING
Study type
OBSERVATIONAL
Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
Start date
2025-01-01
Primary completion
2032-01-01
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.